Brief: Seagen Says 6 Year Overall Survival Results Added To Us Prescribing Information For Adcetris As First-Line Treatment For Advanced Hodgkin Lymphoma
15/06/2023 01:34
June 14 (Reuters) - Seagen Inc SGEN.O :
* SEAGEN- 6 YEAR OVERALL SURVIVAL RESULTS ADDED TO US
PRESCRIBING
INFORMATION FOR ADCETRIS AS FIRST-LINE TREATMENT FOR ADVANCED
HODGKIN LYMPHOMA
Source text for Eikon: ID:nBw7HLm79a
Further company coverage: SGEN.O
((Reuters.Briefs@thomsonreuters.com;;))